Unichem receives ANDA approval for hypertension drug

Unichem receives ANDA approval for hypertension drug

By: IPP Bureau

Last updated : March 16, 2022 12:38 pm



Nebivolol is used alone or together with other medicines to treat high blood pressure


Unichem Laboratories has received ANDA approval for its Nebivolol tablets 2.5 mg, 5 mg, 10 mg, and 20 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Bystolic (nebivolol) tablets 2.5 mg, 5 mg, 10 mg, and 20 mg, of Allergan Sales, LLC.

Nebivolol is used alone or together with other medicines to treat high blood pressure (hypertension).

The product will be commercialized from Unichem's Ghaziabad Plant.

Unichem Laboratories Nebivolol Bystolic

First Published : March 16, 2022 12:00 am